Although the SAVOR and EXAMINE studies were delineated to verify cardiovascular safety of two DPP-4i, namely saxagliptin and alogliptin, respectively, both are considered to be the first controlled clinical trials to address the effect of GLP-1 system on CVD
According to the Cleveland Clinic, significant weight loss in a short space of time can lead to amenorrhea (stopping menstruation)
Exenatide is contraindicated in patients with severe renal impairment (eGFR/CrCl below 30 mL/min), and lixisenatide is not recommended in severe renal impairment (eGFR below 15 mL/min)
EH8965 Size 48T/96T Species Human UniProt ID P09488 Sample Type Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples Detection Method Sandwich ELISA, Double Antibody Detection Wavelength OD450 Reaction Duration 4 hours Range 0.313-20ng/ml Sensitivity 0.188ng/ml Storage 2-8C(Sealed), Don't cryopreserve
That study sheds light on potential other treatments for AUD and brings exciting new questions to researchers
And a Medicaid plan that is administered through UHC has Trulicity listed as a Tier 1 drug with $0 copay, although a prior authorization is required